TP53 and neoplasm: Notably, in non-small cell lung cancer (NSCLC), UBE2T overexpression has been shown to reduce the accumulation of p53 in the cytoplasm, which activates the AMPK/mTOR signaling pathway and enhances autophagy in tumor cells.